The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Sjögren Syndrome‐associated lymphomas: an update on pathogenesis and management
Open accessAbstract
Summary: Primary Sjögren Syndrome ( pSS ) is an autoimmune disease associated with an increased risk of lymphoma. Lymphomas complicating pSS are mostly low‐grade B cell non‐Hodgkin lymphomas, predominantly of marginal zone histological type. Mucosal localization is predominant, notably mucosa‐associated lymphoid tissue lymphomas. Lymphomas often develop in organs where pSS is active, such as salivary glands. Germinal centre (GC)‐like structures, high TNFSF13B (BAFF) and Flt3‐ligand (FLT3LG) levels and genetic impairment of TNFAIP3 are new predictors of lymphoma development. These new findings allow a better understanding of the pathogenic mechanisms leading to lymphoma. We propose the following scenario: auto‐immune B cells with rheumatoid factor (RF) activity are continuously stimulated by immune complexes containing antibodies against more specific auto‐antigens, such as SSA/Ro, SSB/La or others. Germline abnormality of TNFAIP3 leads to a decreased control of the NF‐ kB pathway and thus promotes survival of B cells and oncogenic mutations especially in GC structure. Moreover, B cells are stimulated by a positive loop of activation induced by BAFF secretion. Thus, lymphomagenesis associated with pSS exemplifies the development of antigen‐driven B‐cell lymphoma. The control of disease activity by a well‐targeted immunosuppressor is the primary objective of the management of the patient in order to repress chronic B cell stimulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL
Litinskiy, M. B., Nardelli, B., Hilbert, D. M., He, B., Schaffer, A., Casali, P., & Cerutti, A. (2002) · Nature Immunology · doi:10.1038/ni829 · Cited by 1,252
RetractedWHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
WHO classification of haematolymphoid tumours
Gaillard, F., Weerakkody, Y., & Sharma, R. (2010) · Radiopaedia.org · doi:10.53347/rid-9250 · Cited by 3,776
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J., & Marshak-Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,900
Rummel, M. J., Niederle, N., Maschmeyer, G., Banat, G. A., von Grünhagen, U., Losem, C., Kofahl-Krause, D., Heil, G., Welslau, M., Balser, C., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61763-2 · Cited by 1,510
Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations
Mackay, F., Woodcock, S. A., Lawton, P., Ambrose, C., Baetscher, M., Schneider, P., Tschopp, J., & Browning, J. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.11.1697 · Cited by 1,480
Increased Risk of Lymphoma in Sicca Syndrome
KASSAN, S. S., THOMAS, T. L., MOUTSOPOULOS, H. M., HOOVER, R., KIMBERLY, R. P., BUDMAN, D. R., COSTA, J., DECKER, J. L., & CHUSED, T. M. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-89-6-888 · Cited by 1,012
Seror, R., Ravaud, P., Bowman, S. J., Baron, G., Tzioufas, A., Theander, E., Gottenberg, J.-E., Bootsma, H., Mariette, X., & Vitali, C. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.110619 · Cited by 965
Self-citationEpidemiology of primary Sjögren’s syndrome: a systematic review and meta-analysis
Qin, B., Wang, J., Yang, Z., Yang, M., Ma, N., Huang, F., & Zhong, R. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205375 · Cited by 882
Hermine, O., Lefrère, F., Bronowicki, J.-P., Mariette, X., Jondeau, K., Eclache-Saudreau, V., Delmas, B., Valensi, F., Cacoub, P., Brechot, C., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013376 · Cited by 807
Self-citationThe Risk of Lymphoma Development in Autoimmune Diseases: A Meta-analysis
Zintzaras, E. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.20.2337 · Cited by 771
Ectopic lymphoid-like structures in infection, cancer and autoimmunity
Pitzalis, C., Jones, G. W., Bombardieri, M., & Jones, S. A. (2014) · Nature Reviews Immunology · doi:10.1038/nri3700 · Cited by 698
Ekström Smedby, K., Vajdic, C. M., Falster, M., Engels, E. A., Martínez-Maza, O., Turner, J., Hjalgrim, H., Vineis, P., Seniori Costantini, A., Bracci, P. M., et al. (2008) · Blood · doi:10.1182/blood-2007-10-119974 · Cited by 624
Theander, E., Henriksson, G., Ljungberg, O., Mandl, T., Manthorpe, R., & Jacobsson, L. T. H. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.041186 · Cited by 574
Frequent inactivation of A20 in B-cell lymphomas
Kato, M., Sanada, M., Kato, I., Sato, Y., Takita, J., Takeuchi, K., Niwa, A., Chen, Y., Nakazaki, K., Nomoto, J., et al. (2009) · Nature · doi:10.1038/nature07969 · Cited by 555
The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome
Mariette, X., Roux, S., Zhang, J., Bengoufa, D., Lavie, F., Zhou, T., & Kimberly, R. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.2.168 · Cited by 554
Self-citationfor UK Primary Sjögren's Syndrome Registry, Lessard, C. J., Li, H., Adrianto, I., Ice, J. A., Rasmussen, A., Grundahl, K. M., Kelly, J. A., Dozmorov, M. G., Miceli-Richard, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2792 · Cited by 529
Self-citationIoannidis, J. P. A., Vassiliou, V. A., & Moutsopoulos, H. M. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10221 · Cited by 483
Salomonsson, S., Jonsson, M. V., Skarstein, K., Brokstad, K. A., Hjelmström, P., Wahren‐Herlenius, M., & Jonsson, R. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11311 · Cited by 472
Amft, N., Curnow, S. J., Scheel-Toellner, D., Devadas, A., Oates, J., Crocker, J., Hamburger, J., Ainsworth, J., Mathews, J., Salmon, M., et al. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200111)44:11<2633::aid-art443>3.0.co;2-9 · Cited by 471
Autoimmune and Chronic Inflammatory Disorders and Risk of Non-Hodgkin Lymphoma by Subtype
Smedby, K. E., Hjalgrim, H., Askling, J., Chang, E. T., Gregersen, H., Porwit-MacDonald, A., Sundström, C., Åkerman, M., Melbye, M., Glimelius, B., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj004 · Cited by 439
Coornaert, B., Baens, M., Heyninck, K., Bekaert, T., Haegman, M., Staal, J., Sun, L., Chen, Z. J., Marynen, P., & Beyaert, R. (2008) · Nature Immunology · doi:10.1038/ni1561 · Cited by 434
Royer, B., Cazals-Hatem, D., Sibilia, J., Agbalika, F., Cayuela, J.-M., Soussi, T., Maloisel, F., Clauvel, J.-P., Brouet, J.-C., & Mariette, X. (1997) · Blood · doi:10.1182/blood.v90.2.766 · Cited by 348
Self-citationDe Sanjose, S., Benavente, Y., Vajdic, C. M., Engels, E. A., Morton, L. M., Bracci, P. M., Spinelli, J. J., Zheng, T., Zhang, Y., Franceschi, S., et al. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.02.011 · Cited by 338
Brkić, Z., Maria, N. I., van Helden-Meeuwsen, C. G., van de Merwe, J. P., van Daele, P. L. A., Dalm, V. A. S. H., Wildenberg, M. E., Beumer, W., Drexhage, H. A., & Versnel, M. A. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201381 · Cited by 318
Ittah, M., Miceli‐Richard, C., Gottenberg, J., Lavie, F., Lazure, T., Bâ, N., Sellam, J., Lepajolec, C., & Mariette, X. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1912 · Cited by 307
Self-citationSmedby, K. E., Åkerman, M., Hildebrand, H., Glimelius, B., Ekbom, A., & Askling, J. (2005) · Gut · doi:10.1136/gut.2003.032094 · Cited by 291
Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler, H. G. (1996) · PubMed · Cited by 251
Zucca, E., Conconi, A., Laszlo, D., López-Guillermo, A., Bouabdallah, R., Coiffier, B., Sebban, C., Jardin, F., Vitolo, U., Morschhauser, F., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.6272 · Cited by 229
Epidemiology of primary Sjögren's syndrome in north-west Greece, 1982–2003
Alamanos, Y., Tsifetaki, N., Voulgari, P. V., Venetsanopoulou, A. I., Siozos, C., & Drosos, A. A. (2006) · Rheumatology · doi:10.1093/rheumatology/kei107 · Cited by 222
Bende, R. J., Aarts, W. M., Riedl, R. G., de Jong, D., Pals, S. T., & van Noesel, C. J. M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050068 · Cited by 221
Bombardieri, M., Barone, F., Humby, F., Kelly, S., McGurk, M., Morgan, P., Challacombe, S., De Vita, S., Valesini, G., Spencer, J., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4929 · Cited by 220
Bowman, S., Ibrahim, G., Holmes, G., Hamburger, J., & Ainsworth, Jr. (2004) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740310004676 · Cited by 216
Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study
Fallah, M., Liu, X., Ji, J., Försti, A., Sundquist, K., & Hemminki, K. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu365 · Cited by 206
Gottenberg, J.-E., Seror, R., Miceli-Richard, C., Benessiano, J., Devauchelle-Pensec, V., Dieude, P., Dubost, J.-J., Fauchais, A.-L., Goeb, V., Hachulla, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059868 · Cited by 186
Self-citationTheander, E., & Mandl, T. (2014) · Arthritis Care & Research · doi:10.1002/acr.22264 · Cited by 172
B‐cell non‐Hodgkin's lymphoma and hepatitis C virus infection: A systematic review
Negri, E., Little, D., Boiocchi, M., La Vecchia, C., & Franceschi, S. (2004) · International Journal of Cancer · doi:10.1002/ijc.20205 · Cited by 158
Croia, C., Astorri, E., Murray‐Brown, W., Willis, A., Brokstad, K. A., Sutcliffe, N., Piper, K., Jonsson, R., Tappuni, A. R., Pitzalis, C., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38726 · Cited by 154
Ittah, M., Miceli‐Richard, C., Gottenberg, J., Sellam, J., Eid, P., Lebon, P., Pallier, C., Lepajolec, C., & Xavier Mariette, A. (2008) · European Journal of Immunology · doi:10.1002/eji.200738013 · Cited by 154
Quartuccio, L., Salvin, S., Fabris, M., Maset, M., Pontarini, E., Isola, M., & Vita, S. D. (2012) · Rheumatology · doi:10.1093/rheumatology/kes180 · Cited by 151
Bombardieri, M., Barone, F., Lucchesi, D., Nayar, S., van den Berg, W. B., Proctor, G., Buckley, C. D., & Pitzalis, C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201216 · Cited by 144
Nocturne, G., Boudaoud, S., Miceli‐Richard, C., Viengchareun, S., Lazure, T., Nititham, J., Taylor, K. E., Ma, A. I., Busato, F., Melki, J., et al. (2013) · Blood · doi:10.1182/blood-2013-05-503383 · Cited by 123
Self-citationChanudet, E., Ye, H., Ferry, J. A., Bacon, C. M., Adam, P., Müller-Hermelink, H. K., Radford, J. A., Pileri, S., Ichimura, K., Collins, V. P., et al. (2008) · The Journal of Pathology · doi:10.1002/path.2466 · Cited by 122
Nezos, A., Παπαγεωργίου, Α., Fragoulis, G. E., Ioakeimidis, D., Koutsilieris, M., Tzioufas, A. G., Moutsopoulos, H. Μ., Voulgarelis, M., & Mavragani, C. P. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.04.005 · Cited by 115
Sequencing of TNFAIP3 and association of variants with multiple autoimmune diseases
Musone, S. L., Taylor, K. E., Nititham, J., Chu, C., Poon, A. W., Liao, W. J., Lam, E. T., Ma, A. I., Kwok, P., & Criswell, L. A. (2011) · Genes and Immunity · doi:10.1038/gene.2010.64 · Cited by 114
Weng, M., Huang, Y., Liu, M.-F., & Lu, T. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200402 · Cited by 114
Human B lymphoma cell line producing B cell growth factor.
Ambrus, J. L., & Fauci, A. S. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111754 · Cited by 113
Ray, R. J., Paige, C. J., Furlonger, C. L., Lyman, S. D., & Rottapel, R. K. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260715 · Cited by 111
Development of Autoimmunity in IL-14α-Transgenic Mice
Shen, L., Zhang, C., Wang, T., Brooks, S. R., Ford, R. J., Lin-Lee, Y.-C., Kasianowicz, A., Kumar, V., Martin, L., Liang, P., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5676 · Cited by 104
Lavie, F., Miceli‐Richard, C., Ittah, M., Sellam, J., Gottenberg, J., & Mariette, X. (2008) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2007.02049.x · Cited by 95
Self-citationPollard, R., Pijpe, J., Bootsma, H., Spijkervet, F. K. L., Kluin, P. M., Roodenburg, J. L. N., Kallenberg, C. G. M., Vissink, A., & Imhoff, G. W. V. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.110077 · Cited by 95
Mini ReviewFLT3: Receptor and Ligand
Drexler, H. G., & Quentmeier, H. (2004) · Growth Factors · doi:10.1080/08977190410001700989 · Cited by 92
Pisa, E. K., Pisa, P., Kang, H., & Fox, R. I. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.5.1245 · Cited by 88
Lymphoma development in Sj�gren's syndrome: Novel p53 mutations
Tapinos, N. I., Polihronis, M., & Moutsopoulos, H. Μ. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199907)42:7<1466::aid-anr21>3.0.co;2-l · Cited by 83
IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans
Shen, L., Suresh, L., Li, H., et al. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.10.006 · Cited by 80
Tobón, G. J., Renaudineau, Y., Hillion, S., Cornec, D., Devauchelle‐Pensec, V., Youinou, P., & Pers, J. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27611 · Cited by 77
Ferreri, A. J. M., & Zucca, E. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.04.009 · Cited by 75
Prevalence of Sjogren's syndrome in Slovenia
Tomšič, M. (1999) · British journal of rheumatology · doi:10.1093/rheumatology/38.2.164 · Cited by 69
Paracaspase MALT1 deficiency protects mice from autoimmune-mediated demyelination
Mc Guire, C., Wieghofer, P., Elton, L., Muylaert, D., Prinz, M., Beyaert, R., & van Loo, G. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201351 · Cited by 67 · cited 1×
“The same group demonstrated that MALT1 deficiency protects mice from experimental autoimmune encephalomyelitis partly thanks the prevention of the disappearance of TNFAIP3 (Mc Guire et al, 2013).”
BackgroundGenetic associations to germinal centre formation in primary Sjögren's syndrome
Reksten, T. R., Johnsen, S. J. A., Jonsson, M. V., Omdal, R., Brun, J. G., Theander, E., Eriksson, P., Wahren‐Herlenius, M., Jonsson, R., & Nordmark, G. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202500 · Cited by 61
A failure of TNFAIP3 negative regulation maintains sustained NF-κB activation in Sjögren’s syndrome
Sisto, M., Lisi, S., Lofrumento, D. D., Ingravallo, G., Maiorano, E., & D’Amore, M. (2011) · Histochemistry and Cell Biology · doi:10.1007/s00418-011-0821-3 · Cited by 56
A20 inactivation in ocular adnexal MALT lymphoma
Bi, Y., Zeng, N., Chanudet, E., Huang, Y., Hamoudi, R., Liu, H., Dong, G., Watkins, J. A., Ley, S. C., Zou, L., et al. (2011) · Haematologica · doi:10.3324/haematol.2010.036798 · Cited by 50
Åhlin, E., Mathsson, L., Eloranta, M.-L., et al. (2012) · Lupus · doi:10.1177/0961203311434938 · Cited by 46
Saadoun, D., de Chambrun, M. P., Hermine, O., Karras, A., Choquet, S., Jégo, P., Decaux, O., & Cacoub, P. (2012) · Arthritis Care & Research · doi:10.1002/acr.21856 · Cited by 44
Sang, A. L., Niu, H., Cullen, J. L., Choi, S. C., Zheng, Y. Y., Wang, H., Shlomchik, M. J., & Morel, L. M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303000 · Cited by 38
C-X-C chemokine receptor type 5 gene polymorphisms are associated with non-Hodgkin lymphoma
Song, H., Tong, D., Cha, Z., & Bai, J. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1717-6 · Cited by 28
Cited by
Mariette, X., & Criswell, L. A. (2018) · New England Journal of Medicine · doi:10.1056/nejmcp1702514 · Cited by 947
Self-citationBrito-Zerón, P., Baldini, C., Bootsma, H., Bowman, S. J., Jonsson, R., Mariette, X., Sivils, K., Theander, E., Tzioufas, A., & Ramos-Casals, M. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.47 · Cited by 868
Self-citationEULAR recommendations for the management of Sjogren's syndrome with topical and systemic therapies
Ramos-Casals, M., Brito-Zerón, P., Bombardieri, S., Bootsma, H., De Vita, S., Dörner, T., Fisher, B. A., Gottenberg, J.-E., Hernandez-Molina, G., Kocher, A., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216114 · Cited by 732
Self-citationSjögren’s syndrome: a systemic autoimmune disease
Negrini, S., Emmi, G., Greco, M., Borro, M., Sardanelli, F., Murdaca, G., Indiveri, F., & Puppo, F. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-021-00728-6 · Cited by 459
B cells in the pathogenesis of primary Sjögren syndrome
Nocturne, G., & Mariette, X. (2018) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2018.1 · Cited by 351
Self-citation
Metadata
- Authors
- Nocturne, G., & Mariette, X.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2014-10-15
- Volume
- 168
- Issue
- 3
- Pages
- 317-327
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2023989799
- Cited by
- 295
- References
- 66
- FWCI
- 11.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.